^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MI-2

i
Other names: MI-2
News
Trials
Company:
University of Michigan
Drug class:
Menin-MLL inhibitor
News
Trials